Waters Corporation (WAT)
Automate Your Wheel Strategy on WAT
With Tiblio's Option Bot, you can configure your own wheel strategy including WAT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol WAT
- Rev/Share 50.1902
- Book/Share 49.1826
- PB 10.8544
- Debt/Equity 0.7829
- CurrentRatio 1.8106
- ROIC 0.189
- MktCap 21325681076.0
- FreeCF/Share 10.418
- PFCF 34.4386
- PE 32.42
- Debt/Assets 0.3346
- DivYield 0
- ROE 0.3861
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | WAT | KeyBanc Capital Markets | Sector Weight | Overweight | -- | $460 | March 31, 2025 |
| Upgrade | WAT | Robert W. Baird | Neutral | Outperform | $396 | $407 | March 26, 2025 |
| Upgrade | WAT | Scotiabank | Sector Perform | Sector Outperform | -- | $450 | Feb. 13, 2025 |
| Upgrade | WAT | Barclays | Underweight | Equal Weight | $360 | $415 | Feb. 10, 2025 |
| Upgrade | WAT | Bernstein | Market Perform | Outperform | -- | $430 | Jan. 10, 2025 |
| Initiation | WAT | Scotiabank | -- | Sector Perform | -- | -- | Dec. 23, 2024 |
| Upgrade | WAT | Jefferies | Hold | Buy | $355 | $415 | Oct. 8, 2024 |
| Initiation | WAT | Wells Fargo | -- | Overweight | -- | $380 | Aug. 28, 2024 |
News
Why Waters (WAT) is a Top Growth Stock for the Long-Term
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio
Published: May 21, 2025 by: PRNewsWire
Sentiment: Neutral
MILFORD, Mass. , May 21, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count interfering materials (particles) in therapeutic products, such as cell, protein, and gene therapies.
Read More
Waters Corporation to Present at the Jefferies Global Healthcare Conference
Published: May 16, 2025 by: PRNewsWire
Sentiment: Neutral
MILFORD, Mass. , May 16, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.
Read More
Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
WAT's first-quarter 2025 results reflect strong growth in the instruments and chemical segments, coupled with strong momentum in the industrial and pharma sectors.
Read More
Waters Corporation (WAT) Q1 2025 Earnings Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
Waters Corporation (NYSE:WAT ) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President and Chief Executive Officer Amol Chaubal - Senior Vice President and Chief Financial Officer Conference Call Participants Jack Meehan - Nephron Research LLC Tycho Peterson - Jefferies Puneet Souda - Leerink Partners Catherine Schulte - Robert W. Baird & Co. Sung Ji Nam - Scotiabank Global Banking and Markets Brandon Couillard - Wells Fargo Securities LLC Vijay Kumar - Evercore ISI Matthew Sykes - Goldman Sachs Group, Inc. Daniel Arias - Stifel, …
Read More
Waters (WAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Waters (WAT) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Waters (WAT) Q1 Earnings and Revenues Beat Estimates
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Waters (WAT) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.21 per share a year ago.
Read More
Waters raises 2025 profit forecast on resilient demand for lab equipment
Published: May 06, 2025 by: Reuters
Sentiment: Positive
Waters raised its annual profit forecast on Tuesday, after reporting better-than-expected first quarter results due to higher demand for its medical instruments in Asia and the Americas.
Read More
Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
News Summary Saves up to six months on compliant software validation in biopharmaceutical quality control.1 Reduces analysis time for biotherapeutic peptides and proteins by 20%.2 Enhances quality control by providing absolute molecular weight of biologics and avoiding common errors encountered with other techniques.3 MILFORD, Mass. , May 6, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that its Empower™ Software now supports biologics data acquisition and quality control (QC) analysis from Multi-Angle Light Scattering (MALS) and differential Refractive Index (RI) instruments in its Wyatt Technology™ Portfolio.
Read More
Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
Highlights Strong start to the year as first quarter 2025 sales of $662 million landed at the high-end of guidance range; grew 4% as reported and 7% in constant currency Results led by instrument growth of 11% in constant currency, driven by strong momentum in Pharma and Industrial end markets Earnings landed at the high-end of guidance range with GAAP EPS of $2.03 and non-GAAP EPS of $2.25 Raising full-year constant currency sales growth guidance to +5.0% to +7.0%, given first quarter strength Raising full-year non-GAAP EPS guidance to the range of $12.75 to $13.05, net of tariff impact, operational …
Read More
What Analyst Projections for Key Metrics Reveal About Waters (WAT) Q1 Earnings
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Neutral
Get a deeper insight into the potential performance of Waters (WAT) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Read More
Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?
Published: April 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Waters Corporation to Present at the Leerink Partners Global Healthcare Conference
Published: March 07, 2025 by: PRNewsWire
Sentiment: Neutral
MILFORD, Mass. , March 7, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra Ph.D.
Read More
Waters Corporation: Instrument Replacement Cycle Momentum, But Valuation Is A Concern
Published: February 21, 2025 by: Seeking Alpha
Sentiment: Negative
Waters Corp reported better-than-expected Q4'24 and FY'24 results, driven by strong performance in academia, government, and pharma segments, despite FX headwinds impacting gross margins. The company anticipates continued growth in 2025, with projected revenue growth between 4.5% and 7%, supported by emerging markets like India and high-growth areas like GLP-1 and PFAS testing. Risks include elevated valuations and limited opportunities for cash deployment, making buybacks less attractive; current valuation appears challenging compared to historical averages and peers.
Read More
WAT Earnings & Sales Surpass Estimates in Q4, Shares Rise
Published: February 13, 2025 by: Zacks Investment Research
Sentiment: Neutral
WAT's fourth-quarter 2024 results reflect strong pharma growth and robust gains across all regions. However, forex headwinds hurt.
Read More
Waters Corporation (WAT) Q4 2024 Earnings Call Transcript
Published: February 12, 2025 by: Seeking Alpha
Sentiment: Neutral
Waters Corporation (NYSE:WAT ) Q4 2024 Earnings Conference Call February 12, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President & Chief Executive Officer Amol Chaubal - Senior Vice President & Chief Financial Officer Conference Call Participants Tycho Peterson - Jefferies Vijay Kumar - Evercore ISI Puneet Souda - Leerink Eve Burstein - Bernstein Brandon Couillard - Wells Fargo Dan Arias - Stifel Dan Brennan - TD Cowen Catherine Schulte - Baird Operator Good morning. Welcome to the Waters Corporation Fourth Quarter 2024 Financial Results Conference Call.
Read More
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results
Published: February 12, 2025 by: PRNewsWire
Sentiment: Neutral
Highlights Fourth Quarter 2024 Sales of $873 million exceeded high-end of guidance range, grew 6% as reported and 8% in constant currency Instruments grew 8% and recurring revenue grew 9% in constant currency, as growth accelerated across all three reported regions Pharma grew 10% in constant currency, reflecting stronger-than-expected year-end spending dynamics and broad-based growth across the Americas, Europe, and Asia GAAP EPS of $3.88; non-GAAP EPS of $4.10 grew 13% as strong operational performance and better-than-expected sales volume offset foreign exchange headwinds Full-Year 2024 Sales exceeded guidance at $2,958 million, flat as reported and in organic constant currency GAAP …
Read More
About Waters Corporation (WAT)
- IPO Date 1995-11-17
- Website https://www.waters.com
- Industry Medical - Diagnostics & Research
- CEO Dr. Udit Batra Ph.D.
- Employees 7600